(Q53851412)

English

Unique histopathological features of graft biopsies with liver function abnormalities in living donor liver transplant patients receiving basiliximab induction therapy.

scientific article published in January 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/20236134

Unique histopathological features of graft biopsies with liver function abnormalities in living donor liver transplant patients receiving basiliximab induction therapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/20236134

author name string

Kazushige Sato

1

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/20236134

Satoshi Sekiguchi

2

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/20236134

Naoki Kawagishi

3

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/20236134

Yorihiro Akamatsu

4

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/20236134

Kazuyuki Ishida

5

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/20236134

Daizo Fukushima

6

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/20236134

Shigeto Miyagi

7

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/20236134

Ikuo Takeda

8

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/20236134

Masaaki Yamaguchi

9

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/20236134

Shirou Oguma

10

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/20236134

Keisei Fujimori

11

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/20236134

Akira Sato

12

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/20236134

Susumu Satomi

13

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/20236134

publication date

1 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/20236134

Clinical Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/20236134

25

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/20236134

1

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/20236134

61-68

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/20236134

Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01219.X

21 January 2018

Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01219.X

21 January 2018

Marked Differences in acute cellular rejection rates between living-donor and deceased-donor liver transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01219.X

21 January 2018

Efficacy and safety of basiliximab with a tacrolimus-based regimen in liver transplant recipients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01219.X

21 January 2018

Induction therapy with either anti-CD25 monoclonal antibodies or rabbit antithymocyte globulins in liver transplantation for hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01219.X

21 January 2018

Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01219.X

21 January 2018

Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01219.X

21 January 2018

A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01219.X

21 January 2018

Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01219.X

21 January 2018

Experience with recipient's superficial femoral vein as conduit for middle hepatic vein reconstruction in a right-lobe living donor liver transplant procedure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01219.X

21 January 2018

The renal-sparing efficacy of basiliximab in adult living donor liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01219.X

21 January 2018

Steroid-free living-donor liver transplantation in adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01219.X

21 January 2018

Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01219.X

21 January 2018

Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01219.X

21 January 2018

Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injury

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01219.X

21 January 2018

Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01219.X

21 January 2018

Efficacy and tolerability of interleukin-2 receptor blockade with basiliximab in pediatric renal transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01219.X

21 January 2018

Identifiers

10.1111/J.1399-0012.2010.01219.X

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/20236134

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/20236134

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53851412&oldid=925195503"